Related by context. Frequent words. (Click for all words.) 63 Therein lurks 58 alvimopan 56 Panzem R 56 Presents Positive 55 QNEXA 55 Phase III Clinical Trial 55 Pivotal Phase III 54 R sorafenib tablets 54 RNAi Therapeutics 53 Mipomersen 53 Pirfenidone 53 Allovectin 7 R 53 Pivotal Trial 53 Pivotal Phase 53 Patient Enrollment 53 Pulmonary Arterial Hypertension 53 TOCOSOL Paclitaxel 53 ELND# 53 Virulizin R 53 liprotamase 52 Bicifadine 52 FavId 52 Completes Enrollment 52 Drug Candidate 52 Icatibant 52 Preclinical Data 52 phase IIb clinical 52 MOZOBIL 52 FDA Accepts 52 Cethromycin 52 KRN# 52 Clinical Trial Results 52 injectable formulation 52 tezampanel 52 Investigational Device Exemption 52 dalbavancin 52 Alemtuzumab 52 AeroLEF TM 52 tumor lysis syndrome 51 IND submission 51 pseudobulbar affect PBA 51 Phase 1b trial 51 Small Molecule 51 ganetespib 51 Pennsaid R 51 elotuzumab 51 Stedivaze 51 Phase III Trial 51 Onalta 51 PEG SN# 51 talactoferrin 51 BioDelivery Sciences 51 renal toxicity 51 PREOS 51 BrachySil 51 NEUMUNE 51 Investigational 50 Plenaxis R 50 Marketing Authorization Application 50 Celsion Corporation 50 Traficet EN 50 isavuconazole 50 Ceftobiprole 50 Nasdaq VRTX 50 Augment Bone Graft 50 Topical Interferon Alpha 2b 50 TORISEL 50 clinical trials 50 Exelbine 50 Extended Release 50 omecamtiv mecarbil 50 FDA Orphan Drug 50 alogliptin 50 www.patheon.com 50 Telavancin 50 ImmunoCellular Therapeutics 50 Tranzyme Pharma 49 SILENOR TM 49 External Sensitivity Risk 49 Natalizumab 49 relapsed multiple myeloma 49 Phenoptin 49 ICA # 49 BEMA TM Fentanyl 49 Orphan Drug Status 49 Phase IIa clinical trials 49 diabetic neuropathic pain 49 www.emergentbiosolutions.com 49 prGCD 49 Rhucin ® 49 confirmatory Phase III 49 Clevudine 49 GSK # 49 http:/www.nicusa.com 49 Bone Graft 49 Octreotide 49 Ofatumumab 49 REVLIMID lenalidomide 49 dirucotide 49 preclinical toxicology 49 Amrubicin